Indogulf Cropsciences Limited IPO Review
Neutral105-111 · Mainboard
✦
Analyst Verdict
Indogulf Cropsciences Limited IPO
Neutral
IPO at a Glance
Price Band
105-111
Issue Size
200cr
Opens
2025-06-24
Closes
2025-06-28
Listing
2025-07-01
Category
Mainboard
Key Strengths
✓Among India’s few manufacturers of Pyrazosulfuron Ethyl with 97% purity.
✓Recognized as a Two Star Export House, exporting to 34+ countries.
✓Integrated operations with technical, formulation, and fertilizer plants across four locations.
✓Consistent financial performance with stable operating and net profit margins over FY22–FY24.
✓Strong R&D backed by NABL-certified lab and six granted patents since FY19.
Key Risks
⚠Dependent on regulatory approvals for manufacturing and marketing agrochemicals.
⚠Raw material cost volatility could impact profitability.
⚠Working capital intensive operations with moderate debt levels.
⚠Export risks including currency fluctuations and compliance with international norms.
⚠Any lapses in quality control can lead to order cancellations and litigation.
Frequently Asked Questions
Should I apply for Indogulf Cropsciences Limited IPO?
Based on our analysis, our rating for Indogulf Cropsciences Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Indogulf Cropsciences Limited IPO?
Dependent on regulatory approvals for manufacturing and marketing agrochemicals. Raw material cost volatility could impact profitability. Working capital intensive operations with moderate debt levels.
What are the strengths of Indogulf Cropsciences Limited IPO?
Among India’s few manufacturers of Pyrazosulfuron Ethyl with 97% purity. Recognized as a Two Star Export House, exporting to 34+ countries. Integrated operations with technical, formulation, and fertilizer plants across four locations.
What is the price band of Indogulf Cropsciences Limited IPO?
The price band for Indogulf Cropsciences Limited IPO is 105-111. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more